About this trial

Multicentre observational study of patients with severe tricuspid regurgitation and interventional treatment.

Eligibility criteria

Qualifiers

Interventional treatment of severe tricuspid regurgitation (isolated or in combination with another interventional treatment) with a CE certified product for tricuspid valve repair

Informed consent corresponding to criteria of Good Clinical Practice and the decleration of Helsinki as well as to standards of the local ethic commission.

Disqualifiers

No agreement to participation

Age < 18 years

Trial design

Treatments tested in this trial

  • Interventional treatment of tricuspid regurgitation

Treatment groups

No treatment groups listed

Locations

1
Klinikum der LMU Muenchen Munich Germany

Sponsors and collaborators

LMU Klinikum

Lead sponsor

Heart and Diabetes Center North Rhine-Westphalia

Collaborator

Heart Center Leipzig - University Hospital

Collaborator

Mainz University

Collaborator

Universitätsklinikum Köln

Collaborator

University Hospital, Essen

Collaborator